DOMINANT β-THALASSEMIA DUE TO A NEWLY IDENTIFIED FRAMESHIFT MUTATION IN EXON 3 (CODON 113, GTG → TG)

John S. Waye Provincial Hemoglobinopathy DNA Diagnostic Laboratory, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, L8N 3Z5, Canada; Department of Pathology and Molecular Medecine, McMaster University Medical Centre, Room 3N17, McMaster University Faculty of Health Sciences, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada

Lynda Walker Provincial Hemoglobinopathy DNA Diagnostic Laboratory, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, L8N 3Z5, Canada

John Lafferty St. Joseph's Hospital, Hamilton, Ontario, L8N 4A6, Canada

Edmond G. Lemire Division of Medical Genetics, Department of Pediatrics, University of Saskatchewan and Royal University Hospital, Saskatoon, Saskatchewan, S7N 0W8, Canada

David H. K. Chui Provincial Hemoglobinopathy DNA Diagnostic Laboratory, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, L8N 3Z5, Canada; Department of Pathology and Molecular Medecine, McMaster University Medical Centre, Room 3N17, McMaster University Faculty of Health Sciences, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada

DOMINANT β-THALASSEMIA DUE TO A NEWLY IDENTIFIED FRAMESHIFT MUTATION IN EXON 3 (CODON 113, GTG → TG)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

DOMINANT β-THALASSEMIA DUE TO A NEWLY IDENTIFIED FRAMESHIFT MUTATION IN EXON 3 (CODON 113, GTG → TG)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date